Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma

Clinical trial NCT00650949 · TERMINATED

Trial details

NCT number: NCT00650949
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2009-11-01
Primary completion: 2011-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.